Opinion

Video

Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
NLA 2025: Supporting Whole-Food Dietary Patterns vs Macronutrient Composition for Lipid Management
May 28th 2025

NLA 2025: Supporting Whole-Food Dietary Patterns vs Macronutrient Composition for Lipid Management

Alice H. Lichtenstein, DSc Alana Hippensteele, Lead Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Intestinal carcinoma, colorectal cancer, bowel neoplasia, 3D illustration
May 15th 2025

High LDL Cholesterol Associated With Earlier Progression in Synchronous Metastatic Colorectal Cancer

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Plaque buildup in artery | Image Credit: © SK imagine - stock.adobe.com
May 8th 2025

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Researchers Call for Better Risk Stratification Methods in Older Individuals With Hypercholesterolemia
May 1st 2025

Researchers Call for Better Risk Stratification Methods in Older Individuals With Hypercholesterolemia

Aislinn Antrim, Managing Editor